
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 9.770 | 9.770 | 0.000 |
Shares | 91.730 | 91.730 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 27.890 | 34.289 |
Price to Book | 2.749 | 4.383 |
Price to Sales | 4.743 | 6.568 |
Price to Cash Flow | 20.328 | 25.092 |
Dividend Yield | 1.402 | 1.464 |
5 Years Earnings Growth | 5.079 | 6.365 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 95.730 | 93.904 |
Consumer Defensive | 2.650 | 4.796 |
Consumer Cyclical | 1.620 | 1.032 |
Number of long holdings: 30
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Ningbo Menovo Pharma | CNE100002Y25 | 7.03 | 22.10 | -0.14% | |
Beijing Balance Medical Technology Co | CNE100005X15 | 6.08 | 105.34 | -0.04% | |
Jiangsu Hengrui | CNE0000014W7 | 5.69 | 68.20 | -4.15% | |
SWS Hemodialysis Care | CNE100005VK9 | 5.55 | 15.58 | +3.66% | |
Shenzhen Mindray Bio-Medical | CNE100003G67 | 5.26 | 242.00 | -2.51% | |
Mehow Innovative | CNE100005WP6 | 4.80 | 23.78 | -1.82% | |
TREASURY COUPON BOND 2024 15 | - | 4.74 | - | - | |
Beijing Kawin Technology Shareholding Co | CNE1000054C3 | 4.70 | 27.91 | -0.96% | |
Jiuzhitang A | CNE000001394 | 4.58 | 9.84 | +0.82% | |
Aurisco Pharmaceutical Co | CNE1000042S4 | 4.58 | 22.80 | +0.44% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fuanda Advantage Growth Stock | 601.05M | 70.54 | 13.43 | 11.71 | ||
FuAnDa Emerging Gr Alloc Fd | 59.98M | 45.67 | -8.32 | -3.30 | ||
FuAnDa Strategy Select Balance Fund | 36.9M | 3.82 | -8.98 | 2.49 | ||
FuAnDa Emerging Power Alloc Fd | 8.99M | 21.85 | -10.34 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review